Sabra Health Care REIT Inc
NASDAQ:SBRA

Watchlist Manager
Sabra Health Care REIT Inc Logo
Sabra Health Care REIT Inc
NASDAQ:SBRA
Watchlist
Price: 19.575 USD 2.22% Market Closed
Market Cap: $4.9B

Sabra Health Care REIT Inc
Investor Relations

Sabra Health Care REIT Inc. emerged as a crucial player in the health care real estate sector, weaving its business model around the dynamic needs of senior living and specialized health facilities. Founded in 2010, Sabra was born from the idea of providing reliable financial support to health care operators by investing in their real estate. As a real estate investment trust (REIT), Sabra acquires, owns, and leases properties to operators of skilled nursing facilities, senior housing communities, and hospitals across the United States and Canada. The company derives its income primarily through lease payments from tenants, often structured as triple-net leases, where the operators bear responsibilities for property expenses such as maintenance, insurance, and taxes, ensuring Sabra receives steady, predictable cash flows.

Sabra's strategy involves building a diversified portfolio to mitigate risks, investing in a range of facility types, each catering to different demographics and health care needs. This strategic diversity is a testament to Sabra's understanding of the market's cyclical nature and its adaptability to regulatory changes in the health care environment. The management team at Sabra is seasoned and places significant emphasis on maintaining quality relationships with their operators, ensuring the facilities are not just functional but thrive in providing critical services. By effectively leveraging their real estate assets and adapting to industry trends, Sabra not only contributes to the health care ecosystem but also locks in long-term profitability avenues, all while navigating the complexities of a heavily regulated sector.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

SHOP Portfolio Growth: Sabra's managed SHOP portfolio now makes up 26% of the total, surpassing its previous target. The company is setting a new goal to reach 40% SHOP exposure.

Strong Operating Performance: Same-store managed senior housing saw 13.3% YoY cash NOI growth, with occupancy and RevPAR both rising sequentially.

Investment Activity: Sabra will exceed the high end of its $500 million investment target for 2025, with over $550 million in closed and awarded deals.

Guidance Maintained: 2025 normalized FFO and AFFO per share guidance midpoints remain unchanged, as new investments will impact results more in 2026.

Balance Sheet Strength: Leverage improved to 4.96x net debt/EBITDA; Moody's upgraded Sabra’s credit rating to Baa3.

Dividend and Liquidity: Quarterly dividend of $0.30/share declared, with a payout ratio of 79% of normalized AFFO per share and available liquidity of $1.1 billion.

Key Financials
SHOP Portfolio Contribution
26% of total annualized cash NOI
Cash NOI Growth (SHOP, ex-Holiday)
15.9%
Cash NOI Growth (SHOP, same-store)
13.3%
Occupancy (same-store SHOP portfolio)
86%
Occupancy (Canadian SHOP portfolio)
93.1%
RevPAR Growth (same-store SHOP portfolio)
3.4%
RevPAR Growth (Canadian SHOP portfolio)
5.8%
Cash NOI (managed senior housing portfolio)
$30.1 million
Normalized FFO per share (Q3 2025)
$0.36
Normalized AFFO per share (Q3 2025)
$0.38
Normalized FFO (Q3 2025)
$88.6 million
Normalized AFFO (Q3 2025)
$92.2 million
Cash NOI Margin (managed senior housing portfolio)
up 90 basis points sequentially
Occupancy (total managed portfolio, excluding non-stabilized)
86.8%
RevPAR (total managed portfolio, excluding non-stabilized)
up 4.3% sequentially
Cash Rental Income (triple-net portfolio)
$3.5 million decrease sequentially
Interest and Other Income
$12.7 million
Cash Interest Expense
$26.7 million
Recurring Cash G&A
$9.1 million
Net Debt to Adjusted EBITDA
4.96x
Cost of Permanent Debt
3.94%
Weighted Average Remaining Debt Term
4.4 years
Liquidity
$1.1 billion
Unrestricted Cash and Cash Equivalents
$200.6 million
Available Borrowings under Revolver
$717.8 million
Outstanding Under ATM Forward Contracts
$157.3 million
Dividend per Share (Q3 2025)
$0.30
Dividend Payout Ratio
79% of normalized AFFO per share
Earnings Call Recording
Other Earnings Calls

Management

Mr. Richard K. Matros
Chairman, President & CEO
No Bio Available
Mr. Michael Lourenco Costa CPA
Executive VP, CFO & Secretary
No Bio Available
Ms. Talya Nevo-Hacohen
Executive VP, Chief Investment Officer & Treasurer
No Bio Available
Ms. Jessica Flores
Executive VP, Chief Accounting Officer & Principal Accounting officer
No Bio Available
Mr. Peter W. Nyland
Executive Vice President of Asset Management
No Bio Available
Mr. Darrin L. Smith
Executive Vice President of Investments
No Bio Available
Mr. Lukas Michael Hartwich C.F.A.
Senior Vice President of Finance
No Bio Available
Ms. Eliza Gozar
Senior Vice President of Investments
No Bio Available

Contacts

Address
CALIFORNIA
Irvine
18500 von Karman Ave Ste 550
Contacts
+18883938248.0
www.sabrahealth.com